Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies

NCT05656599 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

CMV Infection
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Letermovir

Sponsor

Peking University People's Hospital